相关实验视频
Updated: May 7, 2025
06:04
Ultrasonographic Assessment During Cardiopulmonary Resuscitation
Published on: October 24, 2020
6.4K
与心力衰竭患者进行心肺复苏讨论的障碍和促进因素
Matilda M M Barnes-Harris1, Sushma Datla2, Alexandra Abel3
1Wolfson Palliative Care Research Centre, Hull York Medical School, University of Hull, Hull, United Kingdom.
PloS one
|December 31, 2024
概括
临床医生和心力衰竭患者从有效的心肺复苏 (CPR) 讨论中受益,当临床医生准备好并患者了解CPR结果时. 过去的建设性谈话激励了参与这些关键的护理规划谈话.
科学领域:
- 心脏病学 心脏病学
- 抚慰性护理是一种缓解性护理.
- 卫生沟通健康沟通
背景情况:
- 先进的心力衰竭护理规划对于适当的治疗和避免心肺复苏 (CPR) 等徒劳干预至关重要.
- 关于心肺复苏的有效沟通对于高级心力衰竭管理中共享决策至关重要.
研究的目的:
- 调查促使临床医生启动和患者/护理人员参与全面心肺复苏 (CPR) 讨论的动机.
- 确定影响高级心力衰竭护理中CPR对话质量和参与度的因素.
主要方法:
- 定性研究采用深入的远程采访,与晚期心力衰竭患者,他们的非正式照顾者和临床医生进行了定性研究.
- 数据分析使用框架分析,与能力,机会,动机-行为变化模型进行映射.
主要成果:
- 两个关键主题出现了:心肺复苏讨论的过程 (准备,行为,影响) 和了解患者的健康状况和心肺复苏结果.
- 临床医生的心肺复苏讨论能力通过准备时间,教育和支持得到了增强.
- 患者和护理人员的参与是由积极的过去经历和对健康状况和心肺复苏预后的现实理解所激励的,促进了共享决策.
结论:
- 积极的先前沟通经验是参与CPR讨论的关键动机.
- 对健康状况和心肺复苏结果的现实理解,以及临床医生的培训,准备和支持,对于有效的心肺复苏讨论至关重要.
- 这些发现强调了需要组织支持和培训,以促进这些重要的对话在先进的心力衰竭护理.
相关概念视频
01:21Barriers to Effective Communication II
3.5K
The barriers to effective communication also include cultural barriers, semantic barriers, gender barriers, and time constraints.
Cultural barriers:
Differences in values, beliefs, religion, knowledge, and tradition can significantly impact communication. Awareness of nonverbal cues is critical, especially when conversing with a patient from a different culture. What appears appropriate in one culture may be inappropriate in another.
Semantic barriers:
As a result of their tendency to use...
Cultural barriers:
Differences in values, beliefs, religion, knowledge, and tradition can significantly impact communication. Awareness of nonverbal cues is critical, especially when conversing with a patient from a different culture. What appears appropriate in one culture may be inappropriate in another.
Semantic barriers:
As a result of their tendency to use...
3.5K
01:22Heart Failure Drugs: β-Blockers
257
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
257
01:17Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
01:30Barriers to Effective Communication I
8.5K
A communication barrier is any distortion or interruption during a conversation, resulting in miscommunication of the message. A good communicator should know these barriers and continuously check for the listener's understanding by obtaining feedback.
Communication barriers include the following:
Physiological barriers: They are limitations caused by a person's health condition or disability, such as hearing loss, poor eyesight, illness, or unconsciousness. An example to overcome this...
Communication barriers include the following:
Physiological barriers: They are limitations caused by a person's health condition or disability, such as hearing loss, poor eyesight, illness, or unconsciousness. An example to overcome this...
8.5K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
299
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
299
01:26Heart Failure Drugs: Inotropic Agents
395
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
395